选择性COX-2抑制剂的发展
刘春霞,杨鸿
摘要(Abstract)：
关键词(KeyWords)：
非甾体类抗炎药;环氧化酶抑制剂
基金项目(Foundation):
作者(Author):
刘春霞,杨鸿
参考文献(References)：
- 1LipskyLP ,AbramsonSB ,CroffordL ,etal.Theclassificationofcyclooxygenaseinhibitors.JRheumatol.1998,25(12):2298～2303
- 2HawkeyCJ .COX 2inhibitors.Lancet.1999,353:307～314
- 3Y .Taniguchi.PharmaceuticalSciences.1995:173～175
- 4PusettiG .Drugs,1993,46(Suppl.1):277～280
- 5MariniU .Drugs,1993,46(Suppl.1):249～252
- 6LaneuvilleO ,BreuerDK ,DeWittDL ,etal.Differentialinhi bitionofhumanprostaglandinendoperoxideHsynthases1and2bynonsteroidalanti inflammatorydrugs.JPharmacolExpTher1994,271:927～934
- 7HankerC ,RahanA ,SteinbruckK ,etal.Gastrointestinaltol erabilityofmeloxicamcomparedtodiclofenacinosteoarthritispatients.BJRheum.1998,37:937～945
- 8DeguekerJ,HawkeyC ,KahanA ,etal.Improvementingastroin testinaltolerabililyoftheselectivecyclooxygenase(COX)2in hibitor,meloxicam,comparedwithpiroxicam,resultsofthesafetyandefficacylargescaleevaluationofCOX inhibitingtherapies(SE LECT)trialinosteoarthritis.BJRheum.1998,37:946～951
- 9黄世杰.默克公司为Rofecoxib提交美国新药申请.国外医学药学分册.1999.26(4):252～253